Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0000875320-24-000162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-30 | 2024-05-28 | VRTX | WAGNER CHARLES F JR | EVP, CFO | S - Sale | $454.79 | -3,250 | 50.4K | -6% | -$1.48M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | S | D | 3,250 | $454.79 | 50,387 | D | — | — |